Success Metrics

Clinical Success Rate

100.0%

Based on 9 completed trials

Completion Rate

100%(9/9)

Active Trials

1(10%)

Results Posted

56%(5 trials)

Phase Distribution

Ph phase_4

20%

Ph phase_3

70%

Ph not_applicable

10%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution10 total trials

Phase 3Large-scale testing

7(70.0%)

Phase 4Post-market surveillance

2(20.0%)

N/ANon-phased studies

1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(9)

Detailed Status

Completed9

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 37 (70.0%)

Phase 42 (20.0%)

N/A1 (10.0%)

Trials by Status

recruiting110%

completed990%

Recent Activity

1 active trials

Showing 5 of 10

recruitingphase_3

Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus

NCT04670666

completedphase_3

Comparing the Effects of Oral Contraceptive Pills Versus Metformin

NCT03229057

completedphase_3

Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia

NCT02827903

completednot_applicable

Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes

NCT02497313

completedphase_3

Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes

NCT01890122

View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials

NCT04670666Phase 3

Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus

Recruiting

NCT03229057Phase 3

Comparing the Effects of Oral Contraceptive Pills Versus Metformin

Completed

NCT02827903Phase 3

Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia

Completed

NCT02497313Not Applicable

Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes

Completed

NCT01890122Phase 3

Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes

Completed

NCT02778776Phase 3

Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome

Completed

NCT02773927Phase 3

Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome

Completed

NCT01438814Phase 4

Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control

Completed

NCT01512979Phase 4

Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes

Completed

NCT01023581Phase 3

Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes

Completed

All 10 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 10